Evidence map›Paper›PMID 36409443›Full record

ArticleVirus genes2023

RHDV 3C protein antagonizes type I interferon signaling by cleaving interferon promoter stimulated 1 protein.

Yanjuan Men, Yonghui Wang, Hui Wang, Maoyin Zhang, Jing Liu, Yang Chen, Xufeng Han, Renjin Chen, Quangang Chen, Ankang Hu

Open access · hybridFull text read
In one paragraph

Article in Virus genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yanjuan Men *School of Life Science, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Yonghui Wang *School of Life Science, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Hui Wang *Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Maoyin ZhangDepartment of Anesthesiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Jing LiuDepartment of Respiratory Medicine, Xuzhou Central Hospital, Xuzhou, Jiangsu, China.
Yang ChenSchool of Life Science, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Xufeng HanSchool of Life Science, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Renjin ChenSchool of Life Science, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Quangang ChenSchool of Life Science, Xuzhou Medical University, Xuzhou, Jiangsu, China. chenquangang@xzhmu.edu.cn.
Ankang HuSchool of Life Science, Xuzhou Medical University, Xuzhou, Jiangsu, China. hak@xzhmu.edu.cn.
Xuzhou Medical College · CNXuzhou Central Hospital · CN

Funding

2022 Experimental Animal Research Fund of the Jiangsu Experimental Animal Association DWXH202206National Natural Science Foundation of China 32172827Natural Science Foundation of Jiangsu Province BK20181153
6 · The paper itself

Abstract

The host innate immune response to viral infection often involves the activation of type I interferons. Not surprisingly, many viruses have evolved various mechanisms to disable the interferon pathway and evade the antiviral response involving innate immunity. Rabbit hemorrhagic disease (RHD) is caused by RHD virus (RHDV), but whether it can antagonize the production of host interferon to establish infection has not been investigated. In this study, we found that during RHDV infection, the expressions of interferon and the interferon-stimulated gene were not activated. We constructed eukaryotic expression plasmids of all RHDV proteins, and found that RHDV 3C protein inhibited poly(I:C)-induced interferon expressions. Using siRNA to interfere with the expressions of TLR3 and MDA5, we found that the MDA5 signal pathway was used by the 3C protein to inhibit poly(I:C)-induced interferon expression. This effect was mediated by cleaving the interferon promoter stimulated 1 (IPS-1) protein. Finally, our study showed that interferon was effective against RHDV infection. In summary, our findings showed that the RHDV 3C protein was a new interferon antagonist. These results increase our understanding of the escape mechanism from innate immunity mediated by the RHDV 3C protein.

Indexed as

Host-Pathogen InteractionsInterferon Type IHemorrhagic Disease Virus, RabbitImmune EvasionImmunity, InnateSignal TransductionViral ProteinsInterferon Type IViral ProteinsImmune evasionInnate immunityInterferonRHDV

Identifiers

PMID36409443
PMCPMC10025200
OpenAlexW4309514321

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read18
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.